一月 2026
- Home
- Grunenthal GmbH
一月 2026的Grunenthal GmbH市场份额分析
Grünenthal is a pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban.
Grunenthal GmbH(包含公司地区分支机构)
查看更多网站流量和参与度信息- grunenthal.com
Grunenthal GmbH收入截至 一月 2026为 > 1B
Grunenthal GmbH主要域名产生的收入
3 年中Grunenthal GmbH主要域名的收入
Grunenthal GmbH主要域名的收入
Grunenthal GmbH热门域名的总访问量
了解Grunenthal GmbH市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Grunenthal GmbH热门域名的平均访问时长
分析Grunenthal GmbH参与度指标。
过去 3 个月的平均访问时长
子公司明细
Grunenthal GmbH热门域名的平均页面浏览量
了解Grunenthal GmbH如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Grunenthal GmbH 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Grünenthal GmbH hires Maren Thurow as vice president and head of global communications.German drugmaker Grünenthal has named Maren Thurow as its new vice president and head of global communications, stepping into the role at a time of significant business expansion and leadership change.
五月 20, 2025阅读更多
新闻Eva leaves Grünenthal GmbH as Senior Global Program Lead.Eva joins from Grünenthal, where she served as Senior Global Program Lead in the pain and inflammation therapeutic area.
四月 9, 2025阅读更多
新闻Grünenthal GmbH acquires Movantik for $250M.Grünenthal has announced the acquisition of US-based Valinor Pharma, along with its opioid-induced constipation (OIC) therapy Movantik, in a $250m deal which includes complete royalty obligations.
七月 23, 2024阅读更多
查看 Grunenthal GmbH 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。